Urogen Pharma Shares Pop After Bull Note

URGN has taken back its 80-day moving average

by Josh Selway

Published on Nov 8, 2018 at 10:56 AM

Urogen Pharma Ltd (NASDAQ:URGN) is trading up 4.5% at $48.49, after Jefferies boosted its price target on the urology expert to $77 -- territory never before explored, and nearly 60% above current levels. URGN shares traded as high as $69.57 back in late May, and has struggled to regain the momentum it had early in the year. Of course, the security still boasts a 30% year-to-date lead, and has made a notable move above previous resistance from the 80-day moving average.

urgn stock price

Analysts are certainly hopeful. All six of those covering URGN have "buy" or "strong buy" ratings, and the average 12-month price target among them is $73.40. The stock will have a chance to live up to these bullish expectations soon, with the company scheduled to report earnings before the open this Monday, Nov. 12.

On the other hand, some traders have started shorting Urogen Pharma. Short interest rose by 11.7% in the last two reporting periods, and the 410,000 shares now sold short represents 7.4 times the average daily trading volume. As such, there is potential for short covering tailwinds for the equity.

Why Hanesbrands Stock Rebound Could Be a Head Fake
HBI's rally into a historically bearish trendline could mark a selling opportunity
Red Flags Waving on Fifth Third Before Earnings
FITB will report earnings bright and early Tuesday morning
Bull Signal Flashing for This Healthcare Stock
The blue chip is pulling back to a historically friendly trendline

a schaeffer's exclusive

2019 TOP STOCK PICKS

Access your FREE insider report before it's too late!


Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


The Moving Average Advice Any Trader Can Follow
How you can transform lagging indicators into leading indicators.
Tiffany Stock Pivots Higher Despite Weak Holiday Sales
Weak fourth-quarter guidance means a new record low for CASA
Trade Headlines Push Stocks Toward Another Positive Week
Positive news on U.S.-China relations helped stocks on Friday
The Moving Average Advice Any Trader Can Follow
How you can transform lagging indicators into leading indicators.